REGENERON PHARMACEUTICALS, INC. (REGN) Operating cash flow 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$5.0BFY2025 · since FY2016: $1.5B → $5.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.0B | +12.6% |
| FY2024 | $4.4B | -3.8% |
| FY2023 | $4.6B | -8.4% |
| FY2022 | $5.0B | -29.2% |
| FY2021 | $7.1B | +170.5% |
| FY2020 | $2.6B | +7.7% |
| FY2019 | $2.4B | +10.7% |
| FY2018 | $2.2B | +67.9% |
| FY2017 | $1.3B | -12.0% |
| FY2016 | $1.5B | — |
Source: SEC XBRL filings · For reference only · Not investment advice